Taking into account these in vitro and biomarkers studies as well as our results of increased expression levels in hypoxic cells and blood of patients, we believe, that Malat1 may have a role as a biomarker of different pathologies, including AKI. This evidence concerns the gene MALAT1 and acute kidney injury.